Structural basis for allosteric PARP-1 retention on DNA breaks
Levani Zandarashvili,Marie-France Langelier,Uday Kiran Velagapudi,Mark A Hancock,Jamin D Steffen,Ramya Billur,Zain M Hannan,Andrew J Wicks,Dragomir B Krastev,Stephen J Pettitt,Christopher J Lord,Tanaji T Talele,John M Pascal,Ben E Black,Mark A. Hancock,Jamin D. Steffen,Zain M. Hannan,Andrew J. Wicks,Dragomir B. Krastev,Stephen J. Pettitt,Christopher J. Lord,Tanaji T. Talele,John M. Pascal,Ben E. Black
DOI: https://doi.org/10.1126/science.aax6367
IF: 56.9
2020-04-03
Science
Abstract:DNA death grip Poly(ADP-ribose) polymerase–1 (PARP-1) binds to DNA breaks and recruits DNA repair components. Cancer-killing PARP-1 inhibitor (PARPi) compounds all block the same catalytic site but exhibit vastly different efficacy. Zandarashvili et al. investigated the molecular impact of PARPi binding to PARP-1 (see the Perspective by Slade and Eustermann). Different PARPi molecules perturb PARP-1 allostery in diverse manners: Some drive allostery to promote release of PARP-1 from DNA, and others drive allostery to promote retention. These insights help explain the different efficacies in the clinic and enable conversion of a pro-release, ineffective cancer-killing compound to a pro-retention, more effective PARPi. Science , this issue p. eaax6367 ; see also p. 30
multidisciplinary sciences